Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name MIR503HG
   Synonyms MIR503HG, H19X, MIR503HG2, MGC16121, H19X
   Region GRCh38_X:134543337-134546632    Sequence
   Ensembl ENSG00000223749
   RefSeq NR_024607
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name choriocarcinoma
   ICD-0-3  M9220/3
   Methods qPCR, Cell transfection, Cell cycle assay etc.
   Sample placenta tissues, cell line (JEG-3)
   Expression Pattern down-regulated
   Function Description

MIR503HG and LINC00629 were lower expressed in JEG-3 cell line than in normal placenta tissues. We found that the overexpression of both lincRNAs could inhibit migration and invasion in JEG-3 choriocarcinoma cell line.Furthermore, using the normal tissue panel, we observed a significant positive correlation between MIR503HG and LINC00629 lincRNAs, and also between both lincRNAs and the neighboring miRNAs: miR-424, miR450a, miR-450b-5p, miR-542-3p and miR-503

   Pubmed ID 27023770
   Year 2016
   Title Placenta-Enriched LincRNAs MIR503HG and LINC00629 Decrease Migration and Invasion Potential of JEG-3 Cell Line.
   External Links
   Links for  MIR503HG GenBank       HGNC       lncrnadb       Noncode
   Links for  choriocarcinoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.